(PharmaNewsWire.Com, December 16, 2017 ) Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver.Rising Prevalence of cancer is proportional to the growth of tumor ablation market. As per data published by the American Cancer Society, the incidence of cancer in United States is 300.2 per 100,000 annually. Similarly in Canada the number is somewhere around 236.6 cases.
North America Tumor ablation market is driven by key factors such as growing geriatric population, increasing number of people affected with cancer, technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and favourable reimbursement structures coupled with rising disposable income are some of the other major factors fuelling the growth of the market. However challenges related to ablation procedures and stringent regulatory guidelines delaying product launches are restraining the market growth.
North America Tumor ablation market is segmented by technology, treatment and application. Based on technology the market is sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body.
On the basis of treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a highest share of around 37% owing to increasing prevalence of liver and breast cancers. By application North America tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.
On the basis of geography North America Tumor Ablation market is segmented into United States and Canada. North America is the largest market for tumor ablation with over 33% share owing to its advanced healthcare infrastructure. Within North America, United States is the largest market due to favourable reimbursement policies and high government support while Canada is estimated to be the fastest growing region due to increasing incidence of cancer.
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
